Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai
Abstracts: Objective: To summarize the use rate, safety, efficacy of antithrombotics in stroke/transient ischemic attack (TIA) prevention, and reasons for not using dabigatran etexilate (DE) in Shanghai, China. Methods: Non-valvular atrial fibrillation (NVAF)-associated stroke patients were prospec...
Guardado en:
Autores principales: | Feng-Di Liu, Rong Zhao, Xue-Mei Wang, Shuo Wang, Xiao-Lei Shen, Xiao-Xiao Tao, Bo Zheng, Jia-Li Peng, Hui Zhang, Ran Mo, Yan Tong, Wen-Ting Li, Xiao-Yan Feng, Ge-Fei Li, Liang Shu, Jian-Ren Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/118a427805ec498eb9fa0c460219d6ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oral anticoagulants for the treatment of venous thromboembolism and non-valvular atrial fibrillation: a cost analysis
por: Isabella C DENARDIN, et al.
Publicado: (2021) -
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013) -
Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models.
por: Brendan L Limone, et al.
Publicado: (2013) -
Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Bo Hu, et al.
Publicado: (2021)